Abstract
A growing tumor undergoes processes of heterogenisation and selection resulting in a complex system that facilitates further growth and progression. Immunosuppressive conditions belong to the hallmarks of this microenvironment, as they prevent efficient anti-cancer immunity. Eligible danger signal seems to be the missing link in the chain of events that would lead to successful elimination of cancer. The concept of bacterial cancer therapy is based on the ability of some microbial species to target tumor site and activate the cancer-specific response via pathogen-associated immunostimulatory signals. To date, a number of bacterial species have been shown to colonize tumor tissue, but strains of Salmonella are particularly interesting, since they meet all the requirements for an ideal tumor-targeting agent: a motile, facultatively anaerobic, intracellular microorganism that is prone to genetic manipulations. The most promising, S. Typhimurium, has multiple adaptations that are therapeutically relevant, including broad host specificity, specialized secretion systems and virulence factors with proapoptotic and immunomodulatory properties. Attenuation of wild-type strains has rendered them safe for preclinical and clinical use, while additional genetic modifications can add to their capacity to kill tumor cells and stimulate anti-cancer immunity. Given the recent developments in the field and the spectrum of possibilities offered by S. Typhimurium and its derivatives, it has a good chance of becoming a novel tool in the anticancer toolbox.
Dedication
In memory of Michał Bereta, who ‘infected’ us with the idea of therapeutic Salmonella
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- APC:
-
Antigen-Presenting Cell
- CEA:
-
CarcinoEmbryonic Antigen
- DAMP:
-
Damage-Associated Molecular Pattern
- DC:
-
Dendritic Cell
- IDO:
-
Indoleamine 2,3-DiOxygenase
- IFN-I:
-
type I InterFeroN
- IFNγ:
-
InterFeroN gamma
- IL:
-
InterLeukin
- LPS:
-
LipoPolySaccharide
- MDSC:
-
Myeloid-Derived Suppressor Cells
- MHC:
-
Major Histocompatibility Complex
- MMP:
-
Matrix MetalloProtease
- MTD:
-
Maximum Tolerated Dose
- PAMP:
-
Pathogen-Associated Molecular Pattern
- scFv:
-
single chain variable fragment antibody
- SCV:
-
Salmonella-Containing Vacuole
- shRNA:
-
short hairpin RNA
- SPI:
-
Salmonella Pathogenicity Island
- STAT3:
-
Signal Transducer and Activator of Transcription 3
- TTSS:
-
Type III Secretion System
- TAA:
-
Tumor-Associated Antigen
- TAM:
-
Tumor-Associated Macrophage
- TLR:
-
Toll-Like Receptor
- TNF:
-
Tumor Necrosis Factor
- TRAIL:
-
TNF-Related Apoptosis-Inducing Ligand
- Treg:
-
regulatory T cell
- VEGF:
-
Vascular Endothelial Growth Factor
References
al-Ramadi BK, Fernandez-Cabezudo MJ, El-Hasasna H, Al-Salam S, Bashir G, Chouaib S (2009) Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clin Immunol 130(1):89–97. doi:10.1016/j.clim.2008.08.021
Anderson DG, Kowalczykowski SC (1998) Reconstitution of an SOS response pathway: derepression of transcription in response to DNA breaks. Cell 95(7):975–979
Angelakopoulos H, Hohmann EL (2000) Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68(4):2135–2141
Avogadri F, Martinoli C, Petrovska L, Chiodoni C, Transidico P, Bronte V, Longhi R, Colombo MP, Dougan G, Rescigno M (2005) Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res 65(9):3920–3927. doi:10.1158/0008-5472.CAN-04-3002
Baker S, Dougan G (2007) The genome of Salmonella enterica serovar Typhi. Clin Infect Dis 45(Suppl 1):S29–S33. doi:10.1086/518143
Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33–40. doi:10.1016/j.semcancer.2011.12.005
Baumler AJ, Tsolis RM, Ficht TA, Adams LG (1998) Evolution of host adaptation in Salmonella enterica. Infect Immun 66(10):4579–4587
Bereta M, Hayhurst A, Gajda M, Chorobik P, Targosz M, Marcinkiewicz J, Kaufman HL (2007) Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine 25(21):4183–4192. doi:10.1016/j.vaccine.2007.03.008
Biragyn A, Longo DL (2012) Neoplastic “Black Ops”: cancer’s subversive tactics in overcoming host defenses. Semin Cancer Biol 22(1):50–59. doi:10.1016/j.semcancer.2012.01.005
Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH (2006) Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 281(16):11374–11383. doi:10.1074/jbc.M509157200
Blache CA, Manuel ER, Kaltcheva TI, Wong AN, Ellenhorn JD, Blazar BR, Diamond DJ (2012) Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth. Cancer Res 72(24):6447–6456. doi:10.1158/0008-5472.CAN-12-0193
Cao HD, Yang YX, Lu L, Liu SN, Wang PL, Tao XH, Wang LJ, Xiang TX (2010) Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumori 96(2):296–303
Chandra D, Gravekamp C (2013) Myeloid-derived suppressor cells: cellular missiles to target tumors. Oncoimmunology 2(11):e26967. doi:10.4161/onci.26967
Chen J, Yang B, Cheng X, Qiao Y, Tang B, Chen G, Wei J, Liu X, Cheng W, Du P, Huang X, Jiang W, Hu Q, Hu Y, Li J, Hua ZC (2012) Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model. Cancer Sci 103(2):325–333. doi:10.1111/j.1349-7006.2011.02147.x
Choi SY, Collins CC, Gout PW, Wang Y (2013) Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230(4):350–355. doi:10.1002/path.4218
Chorobik P, Czaplicki D, Ossysek K, Bereta J (2013) Salmonella and cancer: from pathogens to therapeutics. Acta Biochim Pol 60(3):285–297
Chou CK, Hung JY, Liu JC, Chen CT, Hung MC (2006) An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein. Cancer Gene Ther 13(8):746–752. doi:10.1038/sj.cgt.7700927
Chow MT, Moller A, Smyth MJ (2012) Inflammation and immune surveillance in cancer. Semin Cancer Biol 22(1):23–32. doi:10.1016/j.semcancer.2011.12.004
Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, Li Z, Luo X, King I, Zheng LM (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 181(6):1996–2002. doi:10.1086/315497
Cookson BT, Brennan MA (2001) Pro-inflammatory programmed cell death. Trends Microbiol 9(3):113–114
Cronin M, Morrissey D, Rajendran S, El Mashad SM, van Sinderen D, O’Sullivan GC, Tangney M (2010) Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol Ther 18(7):1397–1407. doi:10.1038/mt.2010.59
Crull K, Bumann D, Weiss S (2011) Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol 62(1):75–83. doi:10.1111/j.1574-695X.2011.00790.x
Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 98(26):15155–15160. doi:10.1073/pnas.251543698
Deng Y, Lin Y, Wu X (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16(1):33–45. doi:10.1101/gad.949602
Deretic V (2011) Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev 240(1):92–104. doi:10.1111/j.1600-065X.2010.00995.x
Desai PT, Porwollik S, Long F, Cheng P, Wollam A, Clifton S, Weinstock GM, McClelland M (2013) Evolutionary genomics of the Salmonella enterica subspecies. mBio 4(2):e00579–12. doi:10.1128/mBio.00579-12
Dresch C, Leverrier Y, Marvel J, Shortman K (2012) Development of antigen cross-presentation capacity in dendritic cells. Trends Immunol 33(8):381–388. doi:10.1016/j.it.2012.04.009
Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991–998. doi:10.1038/ni1102-991
Espert L, Codogno P, Biard-Piechaczyk M (2007) Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med (Berl) 85(8):811–823. doi:10.1007/s00109-007-0173-6
Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL (2007) Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 75(5):2572–2579. doi:10.1128/IAI.01662-06
Fest S, Huebener N, Bleeke M, Durmus T, Stermann A, Woehler A, Baykan B, Zenclussen AC, Michalsky E, Jaeger IS, Preissner R, Hohn O, Weixler S, Gaedicke G, Lode HN (2009) Survivin minigene DNA vaccination is effective against neuroblastoma. Int J Cancer 125(1):104–114. doi:10.1002/ijc.24291
Forbes NS (2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10(11):785–794. doi:10.1038/nrc2934
Forbes JR, Gros P (2003) Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102(5):1884–1892. doi:10.1182/blood-2003-02-0425
Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306. doi:10.1038/nrc3245
Fu W, Chu L, Han X, Liu X, Ren D (2008) Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models. J Gene Med 10(6):690–701. doi:10.1002/jgm.1191
Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res 67(1):425. doi:10.1158/0008-5472.CAN-06-3037; author reply 426
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253–268. doi:10.1038/nri3175
Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S (2013) Tumor associated macrophages and neutrophils in cancer. Immunobiology 218(11):1402–1410. doi:10.1016/j.imbio.2013.06.003
Galen JE, Curtiss R 3rd (2013) The delicate balance in genetically engineering live vaccines. Vaccine 32(35):4376-4385. doi:10.1016/j.vaccine.2013.12.026
Ganai S, Arenas RB, Forbes NS (2009) Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer 101(10):1683–1691. doi:10.1038/sj.bjc.6605403
Garcia-del Portillo F, Zwick MB, Leung KY, Finlay BB (1993) Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. Proc Natl Acad Sci U S A 90(22):10544–10548
Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, Nebuloni M, van Rooijen N, Mortarini R, Beltrame L, Marchini S, Fuso Nerini I, Sanfilippo R, Casali PG, Pilotti S, Galmarini CM, Anichini A, Mantovani A, D’Incalci M, Allavena P (2013) Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 23(2):249–262. doi:10.1016/j.ccr.2013.01.008
Goldszmid RS, Dzutsev A, Trinchieri G (2014) Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe 15(3):295–305. doi:10.1016/j.chom.2014.02.003
Gordon MA (2008) Salmonella infections in immunocompromised adults. J Infect 56(6):413–422. doi:10.1016/j.jinf.2008.03.012
Guan GF, Zhao M, Liu LM, Jin CS, Sun K, Zhang DJ, Yu DJ, Cao HW, Lu YQ, Wen LJ (2013) Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer. Int J Med Sci 10(12):1639–1648. doi:10.7150/ijms.6960
Ha XQ, Yin Q, Zhao HB, Hui L, Wang ML, Peng JH, Dong JZ, Deng ZY, Zhao Y, Zhang YY (2012) Inhibitory effects of the attenuated Salmonella typhimurium containing the IL-2 gene on hepatic tumors in mice. J Biomed Biotechnol 2012:946139. doi:10.1155/2012/946139
Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Hoffman RM (2009a) Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 106(6):992–998. doi:10.1002/jcb.22078
Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM (2009b) Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 8(6):870–875
Heimann DM, Rosenberg SA (2003) Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma. J Immunother 26(2):179–180
Heppner F, Mose JR (1978) The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium. Acta Neurochir (Wien) 42(1–2):123–125
Hernandez LD, Pypaert M, Flavell RA, Galan JE (2003) A Salmonella protein causes macrophage cell death by inducing autophagy. J Cell Biol 163(5):1123–1131. doi:10.1083/jcb.200309161
Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM (2014) Efficacy of Salmonella typhimurium A1-R Versus chemotherapy on a pancreatic cancer Patient-derived orthotopic xenograft (PDOX). J Cell Biochem 115(7):1254–1261. doi:10.1002/jcb.24769
Hong EH, Chang SY, Lee BR, Pyun AR, Kim JW, Kweon MN, Ko HJ (2013) Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic. Vaccine 31(10):1377–1384. doi:10.1016/j.vaccine.2013.01.006
Hu ZQ, Zhao WH (2013) Type 1 interferon-associated necroptosis: a novel mechanism for Salmonella enterica Typhimurium to induce macrophage death. Cell Mol Immunol 10(1):10–12. doi:10.1038/cmi.2012.54
Jarosz M, Jazowiecka-Rakus J, Cichon T, Glowala-Kosinska M, Smolarczyk R, Smagur A, Malina S, Sochanik A, Szala S (2013) Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents. Gene Ther 20(3):262–273. doi:10.1038/gt.2012.28
Jeong JH, Kim K, Lim D, Jeong K, Hong Y, Nguyen VH, Kim TH, Ryu S, Lim JA, Kim JI, Kim GJ, Kim SC, Min JJ, Choy HE (2014) Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium. PLoS One 9(1):e80050. doi:10.1371/journal.pone.0080050
Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12(8):557–569. doi:10.1038/nri3254
Kaimala S, Mohamed YA, Nader N, Issac J, Elkord E, Chouaib S, Fernandez-Cabezudo MJ, Al-Ramadi BK (2014) Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity. Cancer Immunol Immunother 63(6):587–599. doi:10.1007/s00262-014-1543-x
Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188(1):21–28. doi:10.4049/jimmunol.1101029
Kawamoto A, Morimoto YV, Miyata T, Minamino T, Hughes KT, Kato T, Namba K (2013) Common and distinct structural features of Salmonella injectisome and flagellar basal body. Sci Rep 3:3369. doi:10.1038/srep03369
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011–2015
Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF (1998) Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 102(10):1815–1823. doi:10.1172/JCI2466
Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM (2010) Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 43(1):41–48. doi:10.1111/j.1365-2184.2009.00652.x
Knodler LA, Vallance BA, Celli J, Winfree S, Hansen B, Montero M, Steele-Mortimer O (2010) Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc Natl Acad Sci U S A 107(41):17733–17738. doi:10.1073/pnas.1006098107
Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9(12):1004–1010. doi:10.1038/nrm2529
Lahiri A, Das P, Vani J, Shaila MS, Chakravortty D (2010) TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species. PLoS One 5(10):e13772. doi:10.1371/journal.pone.0013772
Le DT, Dubenksy TW Jr, Brockstedt DG (2012) Clinical development of Listeria monocytogenes-based immunotherapies. Semin Oncol 39(3):311–322. doi:10.1053/j.seminoncol.2012.02.008
Lee KC, Zheng L-M, Luo X, Clairmont C, Fischer J, Margitich D, Turnier J, Almassian B, Bermudes D, King I (2000) Comparative evaluation of the acute toxic effects in monkeys, pigs and mice of a genetically engineered salmonella strain (VNP20009) being developed as an antitumor agent. Int J Toxicol 19(1):19–25
Lee JS, Jung ID, Lee CM, Park JW, Chun SH, Jeong SK, Ha TK, Shin YK, Kim DJ, Park YM (2010) Outer membrane protein a of Salmonella enterica serovar Typhimurium activates dendritic cells and enhances Th1 polarization. BMC Microbiol 10:263. doi:10.1186/1471-2180-10-263
Lee CH, Lin ST, Liu JJ, Chang WW, Hsieh JL, Wang WK (2014) Salmonella induce autophagy in melanoma by the downregulation of AKT/mTOR pathway. Gene Ther 21(3):309–316. doi:10.1038/gt.2013.86
Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S (2009) Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 4(8):e6692. doi:10.1371/journal.pone.0006692
Lindgren SW, Stojiljkovic I, Heffron F (1996) Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc Natl Acad Sci U S A 93(9):4197–4201
Loeffler M, Le’Negrate G, Krajewska M, Reed JC (2007) Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci U S A 104(31):12879–12883. doi:10.1073/pnas.0701959104
Loeffler M, Le’Negrate G, Krajewska M, Reed JC (2008) IL-18-producing Salmonella inhibit tumor growth. Cancer Gene Ther 15(12):787–794. doi:10.1038/cgt.2008.48
Loeffler M, Le’Negrate G, Krajewska M, Reed JC (2009) Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol Immunother 58(5):769–775. doi:10.1007/s00262-008-0555-9
Lorenzi S, Mattei F, Sistigu A, Bracci L, Spadaro F, Sanchez M, Spada M, Belardelli F, Gabriele L, Schiavoni G (2011) Type I IFNs control antigen retention and survival of CD8alpha(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming. J Immunol 186(9):5142–5150. doi:10.4049/jimmunol.1004163
Lu H (2014) TLR agonists for cancer immunotherapy: tipping the balance between the immune stimulatory and inhibitory effects. Front Immunol 5:83. doi:10.3389/fimmu.2014.00083
Lu JV, Walsh CM (2012) Programmed necrosis and autophagy in immune function. Immunol Rev 249(1):205–217. doi:10.1111/j.1600-065X.2012.01147.x
Ma Y, Shurin GV, Peiyuan Z, Shurin MR (2013) Dendritic cells in the cancer microenvironment. J Cancer 4(1):36–44. doi:10.7150/jca.5046
Mai CW, Kang YB, Pichika MR (2013) Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther 6:1573–1587. doi:10.2147/OTT.S50838
Manuel ER, Blache CA, Paquette R, Kaltcheva TI, Ishizaki H, Ellenhorn JD, Hensel M, Metelitsa L, Diamond DJ (2011) Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors. Cancer Res 71(12):4183–4191. doi:10.1158/0008-5472.CAN-10-4676
Massa PE, Paniccia A, Monegal A, de Marco A, Rescigno M (2013) Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood 122(5):705–714. doi:10.1182/blood-2012-12-474098
Mastroeni P, Grant A, Restif O, Maskell D (2009) A dynamic view of the spread and intracellular distribution of Salmonella enterica. Nat Rev Microbiol 7(1):73–80. doi:10.1038/nrmicro2034
Matzinger P (2012) The evolution of the danger theory. Interview by Lauren Constable, Commissioning Editor. Expert Rev Clin Immunol 8(4):311–317. doi:10.1586/eci.12.21
McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK (2001) Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413(6858):852–856. doi:10.1038/35101614
McLaughlin LM, Govoni GR, Gerke C, Gopinath S, Peng K, Laidlaw G, Chien YH, Jeong HW, Li Z, Brown MD, Sacks DB, Monack D (2009) The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration. PLoS Pathog 5(11):e1000671. doi:10.1371/journal.ppat.1000671
Meunier E, Dick MS, Dreier RF, Schurmann N, Broz DK, Warming S, Roose-Girma M, Bumann D, Kayagaki N, Takeda K, Yamamoto M, Broz P (2014) Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 509(7500):366–370. doi:10.1038/nature13157
Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3(1):36–46. doi:10.1038/nrmicro1068
Monack DM, Bouley DM, Falkow S (2004) Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 199(2):231–241. doi:10.1084/jem.20031319
Mota LJ, Ramsden AE, Liu M, Castle JD, Holden DW (2009) SCAMP3 is a component of the Salmonella-induced tubular network and reveals an interaction between bacterial effectors and post-Golgi trafficking. Cell Microbiol 11(8):1236–1253. doi:10.1111/j.1462-5822.2009.01329.x
Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM (2009) Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29(6):1873–1878
Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, Litz C, Cavagnolo R, Cahill A, Clairmont C, Sznol M (2003) Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther 10(10):737–744. doi:10.1038/sj.cgt.7700634
Niethammer AG, Lubenau H, Mikus G, Knebel P, Hohmann N, Leowardi C, Beckhove P, Akhisaroglu M, Ge Y, Springer M, Grenacher L, Buchler MW, Koch M, Weitz J, Haefeli WE, Schmitz-Winnenthal FH (2012) Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer. BMC Cancer 12:361. doi:10.1186/1471-2407-12-361
Nishikawa H, Sato E, Briones G, Chen LM, Matsuo M, Nagata Y, Ritter G, Jager E, Nomura H, Kondo S, Tawara I, Kato T, Shiku H, Old LJ, Galan JE, Gnjatic S (2006) In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest 116(7):1946–1954. doi:10.1172/JCI28045
Ochman H, Wilson AC (1987) Evolution in bacteria: evidence for a universal substitution rate in cellular genomes. J Mol Evol 26(1–2):74–86
Olsthoorn MM, Petersen BO, Duus J, Haverkamp J, Thomas-Oates JE, Bock K, Holst O (2000) The structure of the linkage between the O-specific polysaccharide and the core region of the lipopolysaccharide from Salmonella enterica serovar Typhimurium revisited. Eur J Biochem 267(7):2014–2027
Paesold G, Guiney DG, Eckmann L, Kagnoff MF (2002) Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell Microbiol 4(11):771–781
Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J (2009) In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 27(35):5944–5951. doi:10.1200/JCO.2008.19.6147
Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP (1998) Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92(9):3172–3176
Radics J, Konigsmaier L, Marlovits TC (2014) Structure of a pathogenic type 3 secretion system in action. Nat Struct Mol Biol 21(1):82–87. doi:10.1038/nsmb.2722
Ramos-Morales F (2012) Impact of Salmonella enterica type III secretion system effectors on the eukaryotic host cell. ISRN Cell Biol 2012:36. doi:10.5402/2012/787934
Roider E, Jellbauer S, Kohn B, Berchtold C, Partilla M, Busch DH, Russmann H, Panthel K (2011) Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer. Cancer Immunol Immunother 60(3):371–380. doi:10.1007/s00262-010-0950-x
Roland KL, Brenneman KE (2013) Salmonella as a vaccine delivery vehicle. Expert Rev Vaccines 12(9):1033–1045. doi:10.1586/14760584.2013.825454
Ruby T, McLaughlin L, Gopinath S, Monack D (2012) Salmonella’s long-term relationship with its host. FEMS Microbiol Rev 36(3):600–615. doi:10.1111/j.1574-6976.2012.00332.x
Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO (1998) Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281(5376):565–568
Ryter SW, Mizumura K, Choi AM (2014) The impact of autophagy on cell death modalities. Int J Cell Biol 2014:502676. doi:10.1155/2014/502676
Salcedo SP, Noursadeghi M, Cohen J, Holden DW (2001) Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell Microbiol 3(9):587–597
Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF, Guminski A (2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 4(8):675–684. doi:10.1002/emmm.201101131
Schleker S, Sun J, Raghavan B, Srnec M, Muller N, Koepfinger M, Murthy L, Zhao Z, Klein-Seetharaman J (2012) The current Salmonella-host interactome. Proteomics Clin Appl 6(1–2):117–133. doi:10.1002/prca.201100083
Schraidt O, Marlovits TC (2011) Three-dimensional model of Salmonella’s needle complex at subnanometer resolution. Science 331(6021):1192–1195. doi:10.1126/science.1199358
Seo YW, Woo HN, Piya S, Moon AR, Oh JW, Yun CW, Kim KK, Min JY, Jeong SY, Chung S, Song PI, Choi EK, Seol DW, Kim TH (2009) The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release. Cancer Res 69(21):8356–8365. doi:10.1158/0008-5472.CAN-09-0349
Shafer WM, Casey SG, Spitznagel JK (1984) Lipid A and resistance of Salmonella typhimurium to antimicrobial granule proteins of human neutrophil granulocytes. Infect Immun 43(3):834–838
Shahnazari S, Yen WL, Birmingham CL, Shiu J, Namolovan A, Zheng YT, Nakayama K, Klionsky DJ, Brumell JH (2010) A diacylglycerol-dependent signaling pathway contributes to regulation of antibacterial autophagy. Cell Host Microbe 8(2):137–146. doi:10.1016/j.chom.2010.07.002
Song L, Asgharzadeh S, Salo J, Engell K, Wu HW, Sposto R, Ara T, Silverman AM, DeClerck YA, Seeger RC, Metelitsa LS (2009) Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest 119(6):1524–1536. doi:10.1172/JCI37869
Spel L, Boelens JJ, Nierkens S, Boes M (2013) Antitumor immune responses mediated by dendritic cells: how signals derived from dying cancer cells drive antigen cross-presentation. Oncoimmunology 2(11):e26403. doi:10.4161/onci.26403
St Jean AT, Zhang M, Forbes NS (2008) Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol 19(5):511–517. doi:10.1016/j.copbio.2008.08.004
Steiner TS (2007) How flagellin and toll-like receptor 5 contribute to enteric infection. Infect Immun 75(2):545–552. doi:10.1128/IAI.01506-06
Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297(3):151–162. doi:10.1016/j.ijmm.2007.01.008
Sylvester RJ (2011) Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer. Int J Urol 18(2):113–120. doi:10.1111/j.1442-2042.2010.02678.x
Tangney M (2010) Gene therapy for cancer: dairy bacteria as delivery vectors. Discov Med 10(52):195–200
Thamm DH, Kurzman ID, King I, Li Z, Sznol M, Dubielzig RR, Vail DM, MacEwen EG (2005) Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clinical Cancer Res 11(13):4827–4834. doi:10.1158/1078-0432.CCR-04-2510
Thomas DR, Francis NR, Xu C, DeRosier DJ (2006) The three-dimensional structure of the flagellar rotor from a clockwise-locked mutant of Salmonella enterica serovar Typhimurium. J Bacteriol 188(20):7039–7048. doi:10.1128/JB.00552-06
Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F (2009) The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10(11):1215–1221. doi:10.1038/ni.1800
Tome Y, Zhang Y, Momiyama M, Maehara H, Kanaya F, Tomita K, Tsuchiya H, Bouvet M, Hoffman RM, Zhao M (2013) Primer dosing of S. typhimurium A1-R potentiates tumor-targeting and efficacy in immunocompetent mice. Anticancer Res 33(1):97–102
Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20(1):142–152
Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML (2009) Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 16(7):991–1005. doi:10.1038/cdd.2009.8
Umer B, Good D, Anne J, Duan W, Wei MQ (2012) Clostridial spores for cancer therapy: targeting solid tumour microenvironment. J Toxicol 2012:862764. doi:10.1155/2012/862764
Vacchelli E, Eggermont A, Sautes-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L (2013) Trial watch: toll-like receptor agonists for cancer therapy. Oncoimmunology 2(8):e25238. doi:10.4161/onci.25238
van der Velden AW, Baumler AJ, Tsolis RM, Heffron F (1998) Multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect Immun 66(6):2803–2808
Villadangos JA, Shortman K (2010) Found in translation: the human equivalent of mouse CD8+ dendritic cells. J Exp Med 207(6):1131–1134. doi:10.1084/jem.20100985
Voedisch S, Koenecke C, David S, Herbrand H, Forster R, Rhen M, Pabst O (2009) Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice. Infect Immun 77(8):3170–3180. doi:10.1128/IAI.00272-09
Wagner C, Polke M, Gerlach RG, Linke D, Stierhof YD, Schwarz H, Hensel M (2011) Functional dissection of SiiE, a giant non-fimbrial adhesin of Salmonella enterica. Cell Microbiol 13(8):1286–1301. doi:10.1111/j.1462-5822.2011.01621.x
Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5(2):157–163. doi:10.1038/5517
Wang Z, Jiang H, Chen S, Du F, Wang X (2012) The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148(1–2):228–243. doi:10.1016/j.cell.2011.11.030
Wang Y, Chen J, Tang B, Zhang X, Hua ZC (2013) Systemic administration of attenuated in combination with interleukin-21 for cancer therapy. Mol Clin Oncol 1(3):461–465. doi:10.3892/mco.2013.90
Weibel S, Stritzker J, Eck M, Goebel W, Szalay AA (2008) Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 10(6):1235–1248. doi:10.1111/j.1462-5822.2008.01122.x
Whiteside TL (2010) Immune responses to malignancies. J Allergy Clin Immunol 125(2 Suppl 2):S272–S283. doi:10.1016/j.jaci.2009.09.045
Wick MJ (2011) Innate immune control of Salmonella enterica serovar Typhimurium: mechanisms contributing to combating systemic Salmonella infection. J Innate Immun 3(6):543–549. doi:10.1159/000330771
Wynosky-Dolfi MA, Snyder AG, Philip NH, Doonan PJ, Poffenberger MC, Avizonis D, Zwack EE, Riblett AM, Hu B, Strowig T, Flavell RA, Jones RG, Freedman BD, Brodsky IE (2014) Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J Exp Med 211(4):653–668. doi:10.1084/jem.20130627
Xia Y, Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 94(13):6954–6958
Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H (2009) Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res 69(6):2506–2513. doi:10.1158/0008-5472.CAN-08-4323
Yagita H, Takeda K, Hayakawa Y, Smyth MJ, Okumura K (2004) TRAIL and its receptors as targets for cancer therapy. Cancer Sci 95(10):777–783
Yoon WS, Chae YS, Hong J, Park YK (2011) Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-alpha in mice. Appl Microbiol Biotechnol 89(6):1807–1819. doi:10.1007/s00253-010-3006-4
Yoon W, Choi JH, Kim S, Park YK (2014) Engineered Salmonella typhimurium expressing E7 fusion protein, derived from human papillomavirus, inhibits tumor growth in cervical tumor-bearing mice. Biotechnol Lett 36(2):349–356. doi:10.1007/s10529-013-1370-8
Youn JI, Gabrilovich DI (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40(11):2969–2975. doi:10.1002/eji.201040895
Yrlid U, Wick MJ (2000) Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 191(4):613–624
Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, Tang LH, Zheng BJ, Yuen KY, Smith DK, Song E, Huang JD (2012) Explicit hypoxia targeting with tumor suppression by creating an “obligate” anaerobic Salmonella Typhimurium strain. Sci Rep 2:436. doi:10.1038/srep00436
Yu HB, Croxen MA, Marchiando AM, Ferreira RB, Cadwell K, Foster LJ, Finlay BB (2014) Autophagy facilitates Salmonella replication in HeLa cells. mBio 5(2):e00865–e00914. doi:10.1128/mBio.00865-14
Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P (2001) Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res 61(19):7339–7348
Zhang L, Lopez H, George NM, Liu X, Pang X, Luo X (2011) Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways. Cell Death Differ 18(5):864–873. doi:10.1038/cdd.2010.152
Zhang Y, Tome Y, Suetsugu A, Zhang L, Zhang N, Hoffman RM, Zhao M (2012) Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice. Anticancer Res 32(7):2501–2508
Zhang M, Swofford CA, Forbes NS (2013a) Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice. Int J Cancer 135(3):647–657. doi:10.1002/ijc.28700
Zhang Y, Zhang N, Su S, Hoffman RM, Zhao M (2013b) Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture. Anticancer Res 33(5):1837–1843
Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 102(3):755–760. doi:10.1073/pnas.0408422102
Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM (2006) Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66(15):7647–7652. doi:10.1158/0008-5472.CAN-06-0716
Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM (2007) Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A 104(24):10170–10174. doi:10.1073/pnas.0703867104
Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, Liu L, Shao F (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477(7366):596–600. doi:10.1038/nature10510
Zheng YT, Shahnazari S, Brech A, Lamark T, Johansen T, Brumell JH (2009) The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J Immunol 183(9):5909–5916. doi:10.4049/jimmunol.0900441
Zhu X, Zhou P, Cai J, Yang G, Liang S, Ren D (2010) Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma. Cancer Sci 101(12):2621–2628. doi:10.1111/j.1349-7006.2010.01722.x
Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, Noteborn MH (1995) Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 55(3):486–489
Acknowledgements
The authors would like to thank Dr. Grzegorz Bereta for his help with manuscript preparation, especially for the scientific illustration, as well as fruitful discussions. The authors gratefully acknowledge financial support from the Polish National Centre for Research and Development through INNOTECH grant no. 152553 and the funding from the Jagiellonian University within the SET project co-financed by the European Union. Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Kraków is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chorobik, P., Czaplicki, D., Ossysek, K., Bereta, J. (2015). Bacterial Cancer Therapy: How Patients Might Benefit from Salmonella Infections. In: Shurin, M., Thanavala, Y., Ismail, N. (eds) Infection and Cancer: Bi-Directorial Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-20669-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-20669-1_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20668-4
Online ISBN: 978-3-319-20669-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)